Literature DB >> 407246

Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens.

C D Brokopp, R Gomez-Lus, J J Farmer.   

Abstract

A practical slide agglutination test, with commercial antisera (Difco) and live antigens (antigens of live bacteria) taken directly from 24-h antimicrobial susceptibility plates, has been established for serotyping Pseudomonas aeruginosa. Until recently, the lack of both a standard antigenic scheme and a source of commercial antisera has made serological typing of this organism impractical. A simplified procedure with 17 unabsorbed antisera and live antigens prepared from materials readily available in most clinical microbiology laboratories makes epidemiological typing of this organism possible in hospital laboratories. The distribution of each serotype examined in this study was determined by using 425 consecutive patient isolates from six different hospitals. The distribution of O antigen groups (live antigen) was as follows: O1, 11.5%; O2, 1.6%; O3, 3.8%; O4, 7.8%; O5, 4.2% O6, 27.1%; O7,8, 5.9%; O9, 6.8%; O10, 2.4%; O11, 8.2%; O12 through O17, each less than 1%. Ten and six-tenths percent of the above agglutinated in two antisera, 3.3% agglutinated in more than two antisera, and 5.2% did not agglutinate in any antisera. A comparison of live and heated antigens shows that 93.2% were typable with the live antigen, and 94.5% were typable with the heated antigen. When both antigens were used, we typed 96.3% of 725 isolates. The reproductibility and specificity of the serological procedure were examined. We recommend using the live antigen for routine serological typing in clinical microbiology laboratories for "in house" epidemiology and reserving the heated antigen for reference and research typing (and for those few cases where results cannot be obtained using the live antigen). The application of serotyping in the study of outbreaks of P. aeruginosa is also presented.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 407246      PMCID: PMC274671          DOI: 10.1128/jcm.5.6.640-649.1977

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Serological comparison between strains of Pseudomonas aeruginosa from human and animal sources.

Authors:  O SANDVIK
Journal:  Acta Pathol Microbiol Scand       Date:  1960

2.  [Research on O-antigens of Pseudomonas aeruginosa].

Authors:  I HABS
Journal:  Z Hyg Infektionskr       Date:  1957

3.  Study of Dissociative Behavior of Pseudomonas aeruginos.

Authors:  W L Gaby
Journal:  J Bacteriol       Date:  1946-02       Impact factor: 3.490

4.  Observations on bacteriophage typing of Pseudomonas aeruginosa.

Authors:  B POSTIC; M FINLAND
Journal:  J Clin Invest       Date:  1961-11       Impact factor: 14.808

5.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

6.  Preparation of typing antisera specific for O antigens of Pseudomonas aeruginosa.

Authors:  N H Duncan; N A Hinton; J L Penner; I B Duncan
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

7.  Automation of Salmonella typhi phage typing.

Authors:  J J Farmer; F W Hickman; J V Sikes
Journal:  Lancet       Date:  1975-10-25       Impact factor: 79.321

8.  Phage typing of Pseudomonas aeruginosa: clinical and epidemiologic considerations.

Authors:  R B Lindberg; R L Latta
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

9.  Epidemiological markers for pseudomonas aeruginosa.

Authors:  T Bergan; T Midtvedt
Journal:  Acta Pathol Microbiol Scand B       Date:  1975-02

10.  Pyocin typing of Pseudomonas aeruginosa: a simplified method.

Authors:  L F Jones; J P Zakanycz; E T Thomas; J J Farmer
Journal:  Appl Microbiol       Date:  1974-02
View more
  31 in total

1.  Characteristics of Pseudomonas aeruginosa strains causing septicemia in a Spanish hospital 1981-1990.

Authors:  F Vázquez; M C Mendoza; M H Villar; A Vindel; F J Méndez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

2.  Emergence of resistance to beta-lactam agents in Pseudomonas aeruginosa with group I beta-lactamases in Spain.

Authors:  K Colom; A Fdz-Aranguiz; E Suinaga; R Cisterna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

3.  Incidence and mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa serotype O11 isolates.

Authors:  M Kettner; P Milosovic; M Hletková; J Kallová
Journal:  Infection       Date:  1995 Nov-Dec       Impact factor: 3.553

4.  Improved, computer-generated system for pyocin typing of Pseudomonas aeruginosa.

Authors:  B Schable; D R Olson; P B Smith
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

5.  In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates of Pseudomonas aeruginosa.

Authors:  U Vurma-Rapp; F H Kayser
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

6.  Comparison of the Chinese schema and the International Antigenic Typing System for serotyping Pseudomonas aeruginosa.

Authors:  P V Liu
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

7.  Antibiograms, serotypes, and plasmid profiles of Pseudomonas aeruginosa associated with corneal ulcers and contact lens wear.

Authors:  M S Mayo; W L Cook; R L Schlitzer; M A Ward; L A Wilson; D G Ahearn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

8.  Investigations into the survival of Pseudomonas aeruginosa in poloxamer-iodine.

Authors:  R L Anderson; R L Berkelman; D C Mackel; B J Davis; B W Holland; W J Martone
Journal:  Appl Environ Microbiol       Date:  1984-04       Impact factor: 4.792

9.  Cefsulodin sodium therapy in cystic fibrosis patients.

Authors:  I Cabezudo; R L Thompson; R F Selden; S H Guenthner; R P Wenzel
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

10.  Revised pyocin typing method for Pseudomonas aeruginosa.

Authors:  J A Fyfe; G Harris; J R Govan
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.